Soy isoflavones supplementation alleviates disease severity in autoimmune-prone MRL-lpr/lpr mice

Lupus

Volumn 17, Issue 9, 2008, Pages 814-821

  Hong, Y H ^a   Wang, T C ^a   Huang, C J ^a   Cheng, W Y ^a,b   Lin, Bi Fong ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

Author keywords

Autoantibody; IFN ; MRL lpr lpr; Oestrogen receptor; Soy isoflavones

Indexed keywords

CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; ISOFLAVONE DERIVATIVE; PHYTO SOYA; TAMOXIFEN; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY; CYTOKINE; ESTROGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG SELECTIVITY; FEMALE; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; WEIGHT GAIN; ANIMAL; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DIET THERAPY; DRUG EFFECT; IMMUNOLOGY; LONGEVITY; PROTEINURIA; RANDOMIZATION; SOYBEAN;

ANIMALS; ANTIBODIES, ANTINUCLEAR; CYTOKINES; DIETARY SUPPLEMENTS; ESTROGENS; FEMALE; ISOFLAVONES; LONGEVITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED MRL LPR; PROTEINURIA; RANDOM ALLOCATION; SOY FOODS;

EID: 58949098174     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308091287     Document Type: Article

References (55)

1. Lahita RG. The importance of estrogen in systemic lupus erythematosus. Clin Immunol Immunopathol 1992; 63: 17-18.
2. Cooper GS Dooley MA Treadwell EL St. Clair EW Parks CG. Hormonal, environmental, and infectious, risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1714-1724.
3. Whitacre CC Reingold SC O'Looney PA. A gender gap in autoimmunity. Science 1999; 283: 1277-1278.
4. Garovich M Agudelo C Pisko E. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 1980; 23: 1396-1398.
5. Holmdahl R. Estrogen exaggerates lupus but suppresses T-cell-dependent autoimmune disease. J Autoimmun 1989; 2: 651-656.
6. Carlsten H Tarkowski A Holmdahl R Nilsson LA. Oestrogen is a potent disease accelerator in SLE-prone MRL-lpr/lpr mice. Clin Exp Immunol 1990; 80: 467-473.
7. Auborn KJ Qi M Yan XJ. et al. Life span is prolonged in autoimmune-prone (NZB/NZW) F1 mice fed a diet supplemented with indole-3-carbinol. J Nutr 2003; 133: 3610-3613.
8. Jordan VC. Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol 1993; 110: 507-517.
9. Nayfield SG. Tamoxifen's role in chemoprevention of breast cancer: An update. J Cell Biochem 1995; 22(Suppl.): 42-50.
10. Dayan M Zinger H Kalush F. et al. The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations. Immunology 1997; 90: 101-108.
11. Wu WM Lin BF Suen JL Chiang BL. Tamoxifen decreases renal inflammation and alleviates disease severity in autoimmune NZB/W F1 mice. Scand J Immunol 2000; 52: 393-400.
12. Wu WM Suen JL Lin BF Chiang BL. et al. Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice. Immunology 2000; 100: 110-118.
13. Andrews BS Eisenberg RA Theofilopoulos AN. et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978; 148: 1198-1215.
14. Cohen PL Eisenberg RA. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991; 9: 243-269.
15. Pollard KM Pearson DL Hultman P Hildebrandt B Kono DH. Lupus-prone mice as models to study xenobiotic-induce acceleration of systemic autoimmunity. Environ Health Perspect 1999; 107(Suppl. 5): 729S-735S.
16. Birt DF Hendrich S Wang W. Dietary agents in cancer prevention: 9 flavonoids and isoflavonoids. Pharmacol Ther 2001; 90: 157-177.
17. Tsai M Clark JM Schrader WT O'Malley BW. Mechanism of action of hormones that act as transcription-regulatory factors. In: JD Wilson DW Foster HM Kronenberg PR Larsen, (eds), Williams textbook of endocrinology. Philadelphia, PA: WB Saunders Co.; 1998. p. 55-94.
18. Kao TH Wu WM Hung CF Wu WB Chen BH. Anti-inflammatory effects of isoflavone powder produced from soybean cake. J Agric Food Chem 2007; 55: 11068-11079.
19. Velasquez MT Bhathena SJ. Dietary phytoestrogens: A possible role in renal disease protection. Am J Kidney Dis 2001; 37: 1056-1068.
20. American Institute of Nutrition. Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies. J Nutr 1997; 107: 1340-1348.
21. National Research Council. Guide for the care and use of laboratory animals. Bethesda, MD: National Institutes of Health; 1985. Publication No. 85-23.
22. Lin BF Jeng SJ. Effects of dietary frying oil on lipids and anticardiolipin antibody levels in autoimmune-prone NZB/W F1 mice. Nutr Res 1997; 17: 1047.
23. Kuo LC Cheng WY Wu RY Huang CJ Lee KT. Hydrolysis of black soybean isoflavone glycosides by Bacillus subtilis natto. Appl Microbiol Biotechnol 2006; 73: 314-320.
24. Chao CY Huang CJ. Bitter gourd (Momordica charantia) extract activates PPAR and up-regulates the expression of acyl CoA oxidase gene in H4IIEC3 hepatoma cells. J Biomed Sci 2003; 10: 782-791.
25. Hahn BH. Animal models of systemic lupus erythematosus. In: DJ Wallace BH Hahn, (eds), Dubois' lupus erythematosus. Baltimore: Williams, and Wilkins; 1997. p. 339-356.
26. Jonsson R Tarkowski A Backman K Holmdahl R Klareskog L. Sialadenitis in the MRL-l mouse: Morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology 1987; 60: 611-616.
27. Tarkowski A Jonsson R Sanchez R Klareskog L Koopman WJ. Features of renal vasulitis in autoimmune MRL-lpr/lpr mice: Phenotypes and functional properties of infiltrating cells. Clin Exp Immunol 1988; 72: 91-97.
28. Loizou S Samarko M Norsworthy PJ Cazabon JK Walport MJ Davies KA. Significance of anticardiolipin and anti-beta 2-glycoprotein I antibodies in lupus nephritis. Rheumatology 2000; 39: 962-968.
29. Gharavi AE Mellors RC Elkon KB. IgG anti-cardiolipin antibodies in murine lupus. Clin Exp Immunol 1989; 78: 233-238.
30. McNeil HP Chesterman CN Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193-280.
31. Ahmed AS Boone J. Anticardiolipin antibodies in autoimmune-prone BXSB and MRL/lpr mice, and estrogen-treated normal C57BL/6J mice cross-react with other phospholipids. Int J Immunopathol Pharmacol 1993; 6: 135-147.
32. Hashimoto Y Kawamura M Ichikawa K. et al. Anticardiolipin antibodies in NZW×BXSB F1 mice. J Immunol 1992; 149: 1063-1068.
33. Hsieh CC Lin BF. The effects of vitamin E supplementation on autoimmune-prone NZB/W F1 mice fed an oxidized oil diet. Br J Nutr 2005; 93: 655-622.
34. Hsieh CC Lin BF. Opposite effects of low and high dose supplementation of vitamin E on survival of MRL-lpr/lpr mice. Nutrition 2005; 21: 940-948.
35. Li J McMurray RW. Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/NZW F1 mouse model. Clin Immunol 2007; 123: 219-226.
36. Kubo CJohnson BC Day NK Good R. Calorie source, calorie restriction, immunity and aging of NZB/W F1 mice. J Nutr 1984; 114: 1884-1899.
37. Urao M Ueda G Abe M Kanno K Hirose S Shirai T. Food restriction inhibits an autoimmune disease resembling systemic lupus erythematosus in (NZBxNZW) F1 mice. J Nutr 1995; 125: 2316-2324.
38. Aringer M Smolen JS. Cytokine expression in lupus kidneys. Lupus 2005; 14: 13-18.
39. Balomenos D Rumold R Theofilopoulos AN. IFN-γ is required for lupus-like disease and lymphoaccumulation in MRL/lpr mice. J Clin Invest 1998; 101: 364-371.
40. Haas C Ryffel B Hir ML. IFN-γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB×NZW) F1 mice. J Immunol 1998; 160: 3713-3718.
41. Hasegawa K Hayashi T Maeda K. Promotion of lupus in NZB×NZW F1 mice by plasmids encoding interferon (IFN)-γ but not by those encoding interleukin (IL)-4. J Comp Pathol 2002; 127: 1-6.
42. Asanuma Y Chung CP Oeser A. et al. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol 2006; 33: 539-545.
43. Verdrengh M Jonsson IM Holmdahl R Tarkowski A. Genistein as an anti- inflammatory agent. Inflamm Res 2003; 52: 341-346.
44. Hämäläinen M Nieminen R Vuorela P Heinonen M Moilanen E. Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007; 2007: 45673.
45. Chacko BK Chandler RT D'Alessandro TL. et al. Anti-inflammatory effects of isoflavones are dependent on flow and human endothelial cell PPARgamma. J Nutr 2007; 137: 351-356.
46. Calemine J Zalenka J Karpuzoglu-Sahin E Ward DL Lengi A Ahmed SA. The immune system of geriatric mice is modulated by estrogenic endocrine disruptors (diethylstilbestrol, alpha-zearalanol, and genistein): effects on interferon-gamma. Toxicology 2003; 194: 115-128.
47. Rider V Foster RT Evans MJ Suenaga R Abdou NI. Gender differences in autoimmune diseases: Estrogen increases calcineurin expression in systemic lupus erythematosus. Clin Immunol Immunopathol 1998; 89: 171-180.
48. Rider V Jones SR Evans MJ Abdou NI. Molecular mechanism involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin Immunol 2000; 85: 124-134.
49. Sawai C Anderson K Walser-Kuntz D. Effect of bisphenol A on murine function: Modulation of interferon-gamma, IgG2a, and disease symptoms in NZB×NZW F1 mice. Environ Health Perspect 2003; 111: 1883-1887.
50. Kuiper GG Lemmen JG Carlsson B. et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-4263.
51. Curran EM Judy BM Newton LG. et al. Dietary soy phytoestrogens and ERalpha signalling modulate interferon gamma production in response to bacterial infection. Clin Exp Immunol 2004; 135: 219-225.
52. Lambert KC Curran EM Judy BM Milligan GN Lubahn DB Estes DM. Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation. J Immunol 2005; 175: 5716-5723.
53. Imamov O Shim GJ Warner M Gustafsson JA. Estrogen receptor beta in health and disease. Biol Reprod 2005; 73: 866-871.
54. Zhao JH Sun SJ Horiguchi H. et al. A soy diet accelerates renal damage in autoimmune MRL/Mp-lpr/lpr mice. Int Immunopharmacol 2005; 5: 1601-1610.
55. Setchell KD Brown NM Desai P. et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001; 131: 1362S-1375S.